Report ID: PMRREP34571
Number of Pages: 210
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: June-2024
1. Executive Summary
1.1. Global Vaginitis Treatment Drug Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global GDP Growth Outlook
2.3.2. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis
4. Global Vaginitis Treatment Drug Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
4.1. Global Vaginitis Treatment Drug Market Outlook: Drug Class
4.1.1. Introduction / Key Findings
4.1.2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2018 - 2022
4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 - 2031
4.1.3.1. Antibiotics
4.1.3.2. Antifungals
4.1.3.3. Antiprotozoals
4.1.3.4. Others
4.2. Market Attractiveness Analysis: Drug Class
4.3. Global Vaginitis Treatment Drug Market Outlook: Indication
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2018 - 2022
4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
4.3.3.1. Bacterial Vaginitis
4.3.3.2. Yeast Infections (Candidiasis)
4.3.3.3. Trichomoniasis
4.3.3.4. Others
4.4. Market Attractiveness Analysis: Indication
4.5. Global Vaginitis Treatment Drug Market Outlook: Route of Administration
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2018 - 2022
4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
4.5.3.1. Oral
4.5.3.2. Topical
4.5.3.3. Intravaginal
4.6. Market Attractiveness Analysis: Route of Administration
4.7. Global Vaginitis Treatment Drug Market Outlook: Distribution Channel
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2018 - 2022
4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
4.7.3.1. Hospital Pharmacies
4.7.3.2. Retail Pharmacies
4.7.3.3. Online Pharmacies
4.7.3.4. Others
4.8. Market Attractiveness Analysis: Distribution Channel
5. Global Vaginitis Treatment Drug Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Vaginitis Treatment Drug Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Drug Class
6.3.3. By Application
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
6.4.1. U.S.
6.4.2. Canada
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 - 2031
6.5.1. Antibiotics
6.5.2. Antifungals
6.5.3. Antiprotozoals
6.5.4. Others
6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
6.6.1. Bacterial Vaginitis
6.6.2. Yeast Infections (Candidiasis)
6.6.3. Trichomoniasis
6.6.4. Others
6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
6.7.1. Oral
6.7.2. Topical
6.7.3. Intravaginal
6.8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
6.8.1. Hospital Pharmacies
6.8.2. Retail Pharmacies
6.8.3. Online Pharmacies
6.8.4. Others
6.9. Market Attractiveness Analysis
7. Europe Vaginitis Treatment Drug Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Drug Class
7.3.3. By Application
7.3.4. By End-user
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Türkiye
7.4.8. Rest of Europe
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 - 2031
7.5.1. Antibiotics
7.5.2. Antifungals
7.5.3. Antiprotozoals
7.5.4. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
7.6.1. Bacterial Vaginitis
7.6.2. Yeast Infections (Candidiasis)
7.6.3. Trichomoniasis
7.6.4. Others
7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
7.7.1. Oral
7.7.2. Topical
7.7.3. Intravaginal
7.8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
7.8.1. Hospital Pharmacies
7.8.2. Retail Pharmacies
7.8.3. Online Pharmacies
7.8.4. Others
7.9. Market Attractiveness Analysis
8. East Asia Vaginitis Treatment Drug Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Drug Class
8.3.3. By Application
8.3.4. By End-user
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
8.4.1. China
8.4.2. Japan
8.4.3. South Korea
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 - 2031
8.5.1. Antibiotics
8.5.2. Antifungals
8.5.3. Antiprotozoals
8.5.4. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
8.6.1. Bacterial Vaginitis
8.6.2. Yeast Infections (Candidiasis)
8.6.3. Trichomoniasis
8.6.4. Others
8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
8.7.1. Oral
8.7.2. Topical
8.7.3. Intravaginal
8.8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
8.8.1. Hospital Pharmacies
8.8.2. Retail Pharmacies
8.8.3. Online Pharmacies
8.8.4. Others
8.9. Market Attractiveness Analysis
9. South Asia & Oceania Vaginitis Treatment Drug Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Drug Class
9.3.3. By Application
9.3.4. By End-user
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
9.4.1. India
9.4.2. Southeast Asia
9.4.3. ANZ
9.4.4. Rest of South Asia & Oceania
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 - 2031
9.5.1. Antibiotics
9.5.2. Antifungals
9.5.3. Antiprotozoals
9.5.4. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
9.6.1. Bacterial Vaginitis
9.6.2. Yeast Infections (Candidiasis)
9.6.3. Trichomoniasis
9.6.4. Others
9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
9.7.1. Oral
9.7.2. Topical
9.7.3. Intravaginal
9.8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
9.8.1. Hospital Pharmacies
9.8.2. Retail Pharmacies
9.8.3. Online Pharmacies
9.8.4. Others
9.9. Market Attractiveness Analysis
10. Latin America Vaginitis Treatment Drug Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Drug Class
10.3.3. By Application
10.3.4. By End-user
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Rest of Latin America
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 - 2031
10.5.1. Antibiotics
10.5.2. Antifungals
10.5.3. Antiprotozoals
10.5.4. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
10.6.1. Bacterial Vaginitis
10.6.2. Yeast Infections (Candidiasis)
10.6.3. Trichomoniasis
10.6.4. Others
10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
10.7.1. Oral
10.7.2. Topical
10.7.3. Intravaginal
10.8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
10.8.1. Hospital Pharmacies
10.8.2. Retail Pharmacies
10.8.3. Online Pharmacies
10.8.4. Others
10.9. Market Attractiveness Analysis
11. Middle East & Africa Vaginitis Treatment Drug Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
11.3.1. By Country
11.3.2. By Drug Class
11.3.3. By Application
11.3.4. By End-user
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
11.4.1. GCC Countries
11.4.2. Egypt
11.4.3. South Africa
11.4.4. Northern Africa
11.4.5. Rest of Middle East & Africa
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2023 - 2031
11.5.1. Antibiotics
11.5.2. Antifungals
11.5.3. Antiprotozoals
11.5.4. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
11.6.1. Bacterial Vaginitis
11.6.2. Yeast Infections (Candidiasis)
11.6.3. Trichomoniasis
11.6.4. Others
11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
11.7.1. Oral
11.7.2. Topical
11.7.3. Intravaginal
11.8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
11.8.1. Hospital Pharmacies
11.8.2. Retail Pharmacies
11.8.3. Online Pharmacies
11.8.4. Others
11.9. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Pfizer Inc.
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Mylan NV
12.3.2.1. Overview
12.3.2.2. Segments and Products
12.3.2.3. Key Financials
12.3.2.4. Market Developments
12.3.2.5. Market Strategy
12.3.3. Novartis AS
12.3.3.1. Overview
12.3.3.2. Segments and Products
12.3.3.3. Key Financials
12.3.3.4. Market Developments
12.3.3.5. Market Strategy
12.3.4. Bayer AG
12.3.4.1. Overview
12.3.4.2. Segments and Products
12.3.4.3. Key Financials
12.3.4.4. Market Developments
12.3.4.5. Market Strategy
12.3.5. Sanofi S.A.
12.3.5.1. Overview
12.3.5.2. Segments and Products
12.3.5.3. Key Financials
12.3.5.4. Market Developments
12.3.5.5. Market Strategy
12.3.6. Lupin Pharmaceuticals, Inc.
12.3.6.1. Overview
12.3.6.2. Segments and Products
12.3.6.3. Key Financials
12.3.6.4. Market Developments
12.3.6.5. Market Strategy
12.3.7. Dr. Reddy's Laboratories Ltd
12.3.7.1. Overview
12.3.7.2. Segments and Products
12.3.7.3. Key Financials
12.3.7.4. Market Developments
12.3.7.5. Market Strategy
12.3.8. Cipla Ltd.
12.3.8.1. Overview
12.3.8.2. Segments and Products
12.3.8.3. Key Financials
12.3.8.4. Market Developments
12.3.8.5. Market Strategy
12.3.9. Sun Pharmaceutical Industries Limited
12.3.9.1. Overview
12.3.9.2. Segments and Products
12.3.9.3. Key Financials
12.3.9.4. Market Developments
12.3.9.5. Market Strategy
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
